Cheri L. Lubahn, Ph.D.
Affiliations: | 2001 | Arizona State University, Tempe, AZ, United States |
Area:
Immunology, Neuroscience BiologyGoogle:
"Cheri Lubahn"Mean distance: 53433
Parents
Sign in to add mentorDianne Lorton | grad student | 2001 | Arizona State | |
(The role of adrenergic receptors in the expression of cytokines in adjuvant arthritis.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jacobson SA, Simpson RG, Lubahn C, et al. (2015) Characterization of fibromyalgia symptoms in patients 55-95 years old: a longitudinal study showing symptom persistence with suboptimal treatment. Aging Clinical and Experimental Research. 27: 75-82 |
Lubahn CL, Lorton D, Schaller JA, et al. (2014) Targeting α- and β-Adrenergic Receptors Differentially Shifts Th1, Th2, and Inflammatory Cytokine Profiles in Immune Organs to Attenuate Adjuvant Arthritis. Frontiers in Immunology. 5: 346 |
Lorton D, Perez S, Molinaro C, et al. (2014) 149. Lowering splenic sympathetic activity by chronic rilmenidine treatment fails to restore sympathetic neurotransmission in spleens from aging brown norway rats Brain, Behavior, and Immunity. 40: e43 |
Lorton D, Bellinger DL, Schaller JA, et al. (2013) Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis. Clinical & Developmental Immunology. 2013: 764395 |
Perez SD, Kozic B, Molinaro CA, et al. (2012) Chronically lowering sympathetic activity protects sympathetic nerves in spleens from aging F344 rats. Journal of Neuroimmunology. 247: 38-51 |
Lubahn C, Schaller JA, Shewmacker E, et al. (2012) Preclinical efficacy of sodium narcistatin to reduce inflammation and joint destruction in rats with adjuvant-induced arthritis. Rheumatology International. 32: 3751-60 |
Lorton D, Wood C, Lubahn C, et al. (2012) 67. Combined beta-adrenergic-receptor (AR) agonist and alpha-AR antagonist treatment reduced joint damage in adjuvant-induced arthritis without affecting disease-induced sympathetic denervation of the ankle Brain, Behavior, and Immunity. 26: S19 |
Carter JL, Lubahn C, Lorton D, et al. (2011) Adjuvant-induced arthritis induces c-Fos chronically in neurons in the hippocampus. Journal of Neuroimmunology. 230: 85-94 |
Bellinger D, Perez S, Molinaro C, et al. (2011) 158. Chronically reducing sympathetic activity protects sympathetic nerves and alters beta-adrenergic signaling in the aging F344 rat spleen Brain, Behavior, and Immunity. 25: S224-S225 |
Lorton D, Bellinger D, Osredkar T, et al. (2011) Sympathetic signaling to splenocytes is altered in adjuvant induced arthritis (AA) Brain, Behavior, and Immunity. 25: S209 |